{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:51:02Z","timestamp":1793163062895,"version":"4.5.0"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This study aimed to identify the quantified uptake values that can aid the visual interpretation of dopamine transporter (DAT) PET images.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods:<\/jats:title>\n            <jats:p>A total of 155 patients (82 men, 73 women; mean age 67.7 y) who underwent [<jats:sup>18<\/jats:sup>F]-N-(3-fluoropropyl)-2\u03b2-carboxymethoxy-3\u03b2-(4-iodophenyl) nortropane (<jats:sup>18<\/jats:sup>F-FP-CIT) PET scans for suspected Parkinson disease were included. Visual assessments classified <jats:sup>18<\/jats:sup>F-FP-CIT uptake in the basal ganglia [caudate nucleus (CN) and putamen] as normal or abnormal, including the evaluation of asymmetry. The quantitative evaluation involved calculating the SUVR by dividing the basal ganglia SUV by the cerebellum SUV and determining the asymmetric index (AI). This study explored the relationship between these quantification values and visual interpretation, focusing on assessing asymmetric and normal uptake patterns.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Visual analysis indicated that 39.7% (123\/310) of CN and 75.8% (235\/310) of putamen exhibited abnormal <jats:sup>18<\/jats:sup>F-FP-CIT uptake. Significant differences in the SUVR and AI values were observed between the visually normal and abnormal groups (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001 for both the CN and putamen). The SUVR demonstrated excellent diagnostic accuracy for visual normal uptake patterns in the putamen (AUC = 0.950, 93.2% sensitivity, and 89.3% specificity at a cutoff of 3.91) and CN (AUC = 0.932, 87.0% sensitivity, and 87.7% specificity at a cutoff of 2.73). The AI was also significant in evaluating visual asymmetry (AUC = 0.670, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004 for the CN; AUC = 0.855, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001 for the putamen).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our quantitative measures provide valuable support for the visual interpretation of <jats:sup>18<\/jats:sup>F-FP-CIT PET images.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000006063","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T04:03:26Z","timestamp":1754539406000},"page":"e633-e637","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["The Role of Quantification Values in the Visual Interpretation of Dopamine Transporter PET Images"],"prefix":"10.1097","volume":"50","author":[{"given":"Young-Sil","family":"An","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-9848","authenticated-orcid":false,"given":"Jung Han","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ajou University School of Medicine, Suwon, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8658-3523","authenticated-orcid":false,"given":"Dong Gueu","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Neurology, Ajou University School of Medicine, Suwon, Gyeonggi-do, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2096-6115","authenticated-orcid":false,"given":"Su Jin","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Kee","family":"Yoon","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Molecular Imaging"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"R1-20251009","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"R2-20251009","doi-asserted-by":"crossref","first-page":"100037","DOI":"10.1016\/j.dscb.2022.100037","article-title":"A review of diagnostic imaging approaches to assessing Parkinson\u2019s disease","volume":"6","author":"Samson","year":"2022","journal-title":"Brain Dis"},{"key":"R3-20251009","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s13139-013-0253-1","article-title":"Differential diagnosis of patients with inconclusive parkinsonian features using [18 F] FP-CIT PET\/CT","volume":"48","author":"Park","year":"2014","journal-title":"Nucl Med Mol Imaging"},{"key":"R4-20251009","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/acn3.51122","article-title":"Imaging of dopamine transporters in Parkinson disease: a meta-analysis of 18F\/123I-FP-CIT studies","volume":"7","author":"Kong","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"R5-20251009","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1038\/s41598-023-42135-9","article-title":"Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome","volume":"13","author":"Oh","year":"2023","journal-title":"Sci Rep"},{"key":"R6-20251009","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13139-017-0481-x","article-title":"Longitudinal decline of striatal subregional [18 F] FP-CIT uptake in Parkinson\u2019s disease","volume":"51","author":"Sung","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"key":"R7-20251009","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12149-016-1096-5","article-title":"Functional volumetric analysis of striatum using F-18 FP-CIT PET in patients with idiopathic Parkinson\u2019s disease and normal subjects","volume":"30","author":"Jeong","year":"2016","journal-title":"Ann Nucl Med"},{"key":"R8-20251009","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s00259-018-4019-y","article-title":"The role of 18F-FP-CIT PET in differentiation of progressive supranuclear palsy and frontotemporal dementia in the early stage","volume":"45","author":"Yoo","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-20251009","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13139-024-00840-x","article-title":"Imaging procedure and clinical studies of [(18)F]FP-CIT PET","volume":"58","author":"Sung","year":"2024","journal-title":"Nucl Med Mol Imaging"},{"key":"R10-20251009","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"R11-20251009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.12779\/dnd.2017.16.3.57","article-title":"18F-FP-CIT positron emission tomography for correlating motor and cognitive symptoms of Parkinson\u2019s disease","volume":"16","author":"Yang","year":"2017","journal-title":"Dement Neurocogn Disord"},{"key":"R12-20251009","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"R13-20251009","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0404.2011.01583.x","article-title":"[(123) I]FP-CIT-SPECT asymmetry index to differentiate Parkinson\u2019s disease from vascular parkinsonism","volume":"126","author":"Contrafatto","year":"2012","journal-title":"Acta Neurol Scand"},{"key":"R14-20251009","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3390\/diagnostics12061402","article-title":"Diagnostic performance for differential diagnosis of atypical parkinsonian syndromes from Parkinson\u2019s disease using quantitative indices of (18)F-FP-CIT PET\/CT","volume":"12","author":"Cheon","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"R15-20251009","doi-asserted-by":"crossref","first-page":"714","DOI":"10.2967\/jnumed.114.152421","article-title":"Quantitative analysis of (1)(8)F-(E)-N-(3-Iodoprop-2-Enyl)-2beta-Carbofluoroethoxy-3beta-(4\u2019-Methyl-Phenyl) nortropane binding to the dopamine transporter in Parkinson disease","volume":"56","author":"Fazio","year":"2015","journal-title":"J Nucl Med"},{"key":"R16-20251009","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s00259-020-04817-8","article-title":"EANM practice guideline\/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0","volume":"47","author":"Morbelli","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R17-20251009","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/jcbfm.1994.131","article-title":"Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects","volume":"14","author":"Laruelle","year":"1994","journal-title":"J Cereb Blood Flow Metab"},{"key":"R18-20251009","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13139-013-0196-6","article-title":"Feasibility of PET Template-Based Analysis on F-18 FP-CIT PET in Patients with De Novo Parkinson\u2019s Disease","volume":"47","author":"Jeong","year":"2013","journal-title":"Nucl Med Mol Imaging"},{"key":"R19-20251009","first-page":"360","article-title":"Early perfusion and dopamine transporter imaging using (18)F-FP-CIT PET\/CT in patients with Parkinsonism","volume":"8","author":"Hong","year":"2018","journal-title":"Am J Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006063","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:04:06Z","timestamp":1760025846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006063","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"2024-06-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}